Finnish Blood Testing Startup Is Going Beyond The Theranos Dream
Finnish blood testing startup Nightingale is looking to solve the global burden of chronic disease. With interest in blood-testing startups growing, I sat down with CEO Teemu Suna to find out how they plan on building personalized healthcare, and how the Theranos fraud case has affected them.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Gemma Milne, Contributor Source Type: news
More News: Finland Health | Pharmaceuticals